Silicon Valley startups are offering embryo screening for traits like intelligence and appearance, sparking debate over the ethics and science of genetic selection.
In the United States, several start-ups now offer future parents to compare their embryos according to their risk of disease, but also their estimated size or IQ. A still marginal and highly contested practice, which revives the debate on the limits of genetic selection.